This virtual symposium will highlight new strategies to develop therapeutics for Alzheimer’s disease, with an emphasis on non-amyloid targets. The ..
latest research will be featured on topics including neurogenesis, neuroprotection, lifestyle factors, and brain-peripheral organ interaction, with an emphasis on showcasing promising avenues for therapeutic development in AD. Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Featuring the next generation of leading researchers in the field, this symposium will share the latest findings in the study of tumor metabolism, and how altered metabolic pathways can be targeted for cancer therapeutics. This three day event will highlight the latest research in the field including discussion of how insights from the immune response to infection can inform our understanding of cancer immunotherapy, the COVID-19/Immuno-oncology interface, advances in multiple myeloma, cytokines, novel checkpoints and more. Explore in this one-day symposium new scientific understanding related to the neurobiology of mental illnesses — including talks on historical perspectives, patient-derived brain-based mechanistic studies, guided therapeutic target selection, mechanisms of motivational and cognitive deficits, clinical staging in psychiatry, the genetic architecture of psychiatric disorders, and more.